Related Experiment Video
Updated: Aug 9, 2025
08:56
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Published on: February 10, 2015
52.6K
Alginate Oligosaccharides Repair Liver Injury by Improving Anti-Inflammatory Capacity in a Busulfan-Induced Mouse
Yanan Hao1,2,3,4, Hanhan Fang2,4, Xiaowei Yan2
1Laboratory of Animal Reproductive Physiology and Disease, College of Veterinary Medicine, Qingdao Agricultural University, Qingdao 266109, China.
International Journal of Molecular Sciences
|February 25, 2023
Summary
Alginate oligosaccharides (AOS) show promise in treating liver damage by reducing inflammation. This study found AOS effectively improved liver function and related blood metabolites in mice, offering a potential low-cost therapy.
Area of Science:
- Biochemistry
- Pharmacology
- Hepatology
Background:
- Liver diseases pose a significant global health challenge, often accompanied by inflammatory complications.
- Current therapeutic strategies may have limitations, necessitating the exploration of novel treatments.
- Alginate oligosaccharides (AOS) are known for their anti-inflammatory properties, suggesting potential therapeutic applications.
Purpose of the Study:
- To investigate the efficacy of alginate oligosaccharides (AOS) as a potential therapeutic agent for liver injury.
- To evaluate AOS's effects on inflammation-related factors and liver function in a mouse model.
- To explore AOS as a low-cost, no-side-effect treatment for liver diseases.
Main Methods:
- A mouse model of liver injury was induced using busulfan injection.
- Mice were administered either distilled water (ddH2O) or AOS (10 mg/kg BW) daily via oral gavage for five weeks.
- Liver injury, inflammation markers, blood metabolites, and liver function were assessed.
Main Results:
- AOS administration significantly recovered liver injury induced by busulfan.
- AOS treatment decreased levels of inflammation-related factors in the liver.
- AOS improved blood metabolites associated with immune and anti-tumor effects, ameliorating impaired liver function.
Conclusions:
- Alginate oligosaccharides (AOS) demonstrate significant therapeutic potential for liver damage, particularly when associated with inflammation.
- AOS effectively mitigates liver injury by modulating inflammatory pathways and improving key blood metabolites.
- AOS represents a promising, low-cost, and potentially side-effect-free therapeutic option for liver diseases.
